Skip to content

Our 2022 Picks: How did we get on in November?


Having sold out of quite a few positions in October, we held onto pretty much everything in November except for closing our short on NIVIDIA. Health Equity was close to being sold as we moved into December. The market remains a very difficult one to judge tactically as traders remain very jumpy about any macroeconomic news, especially any numbers coming out of the US and China. These seemed primed to affect sentiment in November.


We added Tesla as a short trade in November. Our thesis for Tesla [NASDAQ:TSLA] remains the same - it is currently in the process of conceding its first mover advantage to other EV manufacturers, and in our view the share price does not reflect the fundamentals of the company. It is being supported by a large 'fan boy' base of investors, but really, can it sustain this for much longer?  We shorted the stock at $190 on 18 November. It tried to rally later in the month (up at around $194 at the end of November) but did not endanger our risk limits. At time of writing it is currently trading at $162 leaving the trade well in the money.

Brent crude oil

We noticed some major dynamics coming into play in mid-November which warranted the addition of a short trade on Brent crude. High oil prices have been a big feature of 1H 2022, but the dynamics seem to have shifted considerably. The world energy market is adjusting to the conflict in Ukraine and new sources of oil look set to come online in 2023 (e.g. we note progress in US talks with Venezuela). The other big issue seems to be the ongoing problems with China's economy, where the zero-tolerance Covid policy continued to hit the country's industrial sector.  We entered the trade short at $92.58 using the February 2023 futures contract (ICE)) as our benchmark. Our +6.06% gain would obviously be significantly magnified via a leveraged trade like a x10 CFD.

Kodiak Copper Corp

We have kept this copper explorer as a buy and hold venture stock on our portfolio for quite some time. Although we are already up 300% on our entry price, we remain positive about its prospects. We caught up briefly with CEO Claudia Tornquist at the Mines & Money conference in London in November. Shares in the copper explorer are on the move again and news of on the surface gold is also going to provide further support for the stock price. Kodiak recently completed its exploration at its large MPD site in British Columbia and says it is planning "another sizable exploration program" in 2023. It drilled 41 holes over more than 26,000 metres at its Gate/Prime and Dillard targets. Further assays are anticipated in the New Year, so watch this space.

Atlas Salt

Another big winner for us in the small cap stakes in salt miner Atlas Salt. We caught up with the management team when they visited London this autumn. Sources close to the company tell us that it is close to reporting project economics for its Great Atlantic Salt Deposit in Newfoundland. A PEA is anticipated in mid-January with a Feasibility Study to follow soon afterwards. As a homogenous deposit, with similar DNA to Goderich in southern Ontario, it is already yielding potentially industry-beating salt cores, according to Rowland Howe, President of Atlas Salt. In a sector dominated by ageing mines, almost all of which are more than half a century old, Great Atlantic is being designed to operate like a highly efficient ‘Salt Factory’ serving eastern Canada and the U.S. eastern seaboard.

Sold this month: NVIDIA Corp (closed short)

So how are are picks getting on?

Want the full story? Access all of The Armchair Trader's content for just £5.99 per month.

Get weekly investment ideas and tips that will take your investing to the next level. Sign up here.

Free 28 day trial. Cancel anytime.

Log In or Sign Up to Armchair Trader+

Already a member? Log in here:

Not a member yet? Sign up for your free trial or check out the benefits of membership.

Further content of this article is not available as it is for members only. Please visit the registration page for Armchair Trader Plus+ for further details on the benefits of becoming a member.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

CME Group
FP Markets
Back To Top